Location History:
- Leperray, FR (1996)
- Auffargis, FR (2002)
Company Filing History:
Years Active: 1996-2002
Title: Pierre-Oliver Couraud: Innovator in Pharmaceutical Compositions
Introduction
Pierre-Oliver Couraud is a notable inventor based in Auffargis, France. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of autoimmune conditions. With a total of 2 patents, his work focuses on innovative drug delivery systems and the detection of lectin-expressing cells.
Latest Patents
Couraud's latest patents include groundbreaking research on the use of HL-60-related lectins in drug delivery. One of his patents describes pharmaceutical compositions that are useful in treating autoimmune conditions. These compositions contain a soluble lectin with a molecular weight of about 14 kilodaltons, which binds to β-galactoside-containing moieties. This lectin stimulates hemagglutination in standard assays and is effective in treating conditions such as rheumatoid arthritis, myasthenia gravis, and multiple sclerosis. Additionally, he has developed methods for producing human HL-60 lectin, which is specific for beta-D-galactosides and can be utilized in various hosts.
Career Highlights
Couraud is currently associated with Incyte Pharmaceuticals, Inc., where he continues to advance his research in the pharmaceutical field. His innovative approaches have the potential to significantly impact the treatment of autoimmune diseases and improve patient outcomes.
Collaborations
Some of his notable coworkers include Glenn E Nedwin and Timothy S Bringman, who have collaborated with him on various projects within the pharmaceutical industry.
Conclusion
Pierre-Oliver Couraud's contributions to pharmaceutical innovations highlight his expertise in drug delivery systems and autoimmune treatments. His work continues to pave the way for advancements in medical science and patient care.